African-Americans are less likely than whites to receive critical stroke treatment primarily because they do not get to a hospital soon enough for time-sensitive treatment and because of preexisting medical conditions. For ...
Jun 30, 2011
0
0
A targeted, nanoparticle gelatin-based clot-busting treatment dissolved significantly more blood clots than a currently used drug in an animal study of acute coronary syndrome presented at the American Heart Association's ...
Nov 14, 2011
0
0
Stroke claims five million lives worldwide each year and is the second biggest killer after ischaemic heart disease. Of those who survive, a significant number (around five million) live with neurological deficits that profoundly ...
Mar 17, 2014
0
0
The only drug currently approved for treatment of stroke's crippling effects shows promise, when administered as a nasal spray, to help heal similar damage in less severe forms of traumatic brain injury.
Oct 7, 2014
0
0
Innovative angles of attack in research that focus on how the human brain protects and repairs itself will help develop treatments for one of the most common, costly, deadly and scientifically frustrating medical conditions ...
Mar 23, 2015
0
14
A molecular substance that occurs naturally in humans and rats was found to "substantially reduce" brain damage after an acute stroke and contribute to a better recovery, according to a newly released animal study by researchers ...
Mar 11, 2014
0
0
(HealthDay)—Use of lean process improvement methodology can reduce the time to stroke care without compromising patient safety, according to a study published online Nov. 8 in Stroke.
Nov 10, 2012
0
0
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This ...
Jun 26, 2012
0
0
After analyzing stroke treatment records, researchers at Rhode Island Hospital in collaboration with researchers from the University of Cincinnati learned that women and men have different reasons for being excluded from ...
Apr 6, 2015
0
2
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...
Feb 20, 2018
0
41
